Secukinumab Biosimilar - Research Grade
Bulk Secukinumab Biosimilar - Research Grade
Product Benefits:ichorbio's Secukinumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility.
Size:ichorbio's research grade secukinumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg,100mg ichorbio regularly manufactures bulk multi-gram amounts of our secukinumab biosimilar - please contact us for pricing.
Target:IL-17A
Clone:n/a
Isotype:IgG1 kappa
Other Names:Interleukin-17A, IL17A, CTLA-8, CTLA8
Host:Humanized
Species Reactivity:Human
Specificity:Detects human IL17A.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Secukinumab is a recombinant human monoclonal IgG1/κ antibody that binds specifically to IL-17A. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line. Secukinumab has a molecular mass of approximately 151 kDa; both heavy chains of secukinumab contain oligosaccharide chains.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, clear to milky white, colorless to slightly yellow solution, with a pH of 5.8, containing L-histidine/histidine monohydrate hydrochloride, polysorbate 80, and sucrose. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 0.75 EU/mg as determined by the LAL method
Storage:Secukinumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's secukinumab biosimilar is for research use only (RUO). Isotype Control:| Concentration | 8.75mg/ml |
|---|---|
| Isotype | IgG1 kappa |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human IL17A. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Secukinumab. |
| Species Reactivity | Human |
| Target | IL17A |
| Shipping Conditions | Blue ice |
| background | Secukinumab is a recombinant human monoclonal IgG1/_ antibody that binds specifically to IL-17A. It is expressed in a recombinant Chinese Hamster Ovary (CHO) cell line. Secukinumab has a molecular mass of approximately 151 kDa; both heavy chains of secuki |
| Other names | Interleukin-17A, IL17A, CTLA-8, CTLA8 |
| UniProt | Q16552 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |